John G Ullman & Associates Inc Boston Scientific Corp Transaction History
John G Ullman & Associates Inc
- $631 Million
- Q4 2024
A detailed history of John G Ullman & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, John G Ullman & Associates Inc holds 2,391 shares of BSX stock, worth $251,652. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,391Holding current value
$251,652% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,596Shares Held
1.19BCall Options Held
6.83MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$13.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.61 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.98 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.45 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $151B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...